Archives
-
5-Methyl-CTP for Robust mRNA Synthesis
2026-09-12
Use 5-Methyl-CTP to build a controlled mRNA synthesis workflow that evaluates transcript integrity, expression, and delivery performance together. The approach connects modified nucleotide selection with practical vaccine, gene-expression, and mRNA drug development assays while keeping formulation and sequence effects separate.
-
Caspase-3/7 Inhibitor I as a Pathway Probe
2026-09-11
Caspase-3/7 Inhibitor I provides a reversible, cell-permeable way to test whether apoptosis depends on executioner caspases. This article applies that precision tool to phase-specific Candida krusei signaling in bovine mammary epithelial cells and explains how to design more causally informative assays.
-
Arginine Methylation, FUS, and Neuronal Granules
2026-09-11
Wang and Li show that asymmetric dimethylation of FUS enables multivalent engagement with oligomeric SMN, lowering the phase-separation barrier for neuronal granule assembly. Their rescue and loss-of-function experiments connect this molecular mechanism to axonal mRNA distribution, neuronal activity, and disease-relevant SMN valency.
-
Elobixibat Hydrate: IBAT Mechanism and Evidence
2026-09-10
Elobixibat hydrate is a highly selective ileal bile acid transporter inhibitor that increases colonic bile acid exposure and supports intestinal motility. Product information supports research and clinical-context discussion of chronic idiopathic constipation, while the E-PLUS publication describes an ongoing randomized protocol rather than completed colonoscopy efficacy results.
-
Fenofibrate: Decoding PPARα–YAP Assays
2026-09-10
Fenofibrate is more than a PPARα agonist or viability reagent: it is a mechanistic probe linking lipid metabolism, hepatic adaptation, and YAP signaling. This article presents an evidence-layered strategy for interpreting Fenofibrate assays across aging, liver, and cancer biology research.
-
CBD in Orofacial Inflammatory Pain: Mechanisms
2026-09-09
This 2026 Brain Research Bulletin study shows that cannabidiol reduces both sensory pain and pain-related affective deficits in mouse models through distinct peripheral and central mechanisms. Its integrated use of behavioral testing, molecular profiling, and fiber photometry provides a useful framework for evaluating inflammatory pain therapies beyond nociception alone.
-
Esflurbiprofen and Fast-Onset Antidepressant Action
2026-09-09
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the SERT–nNOS complex in the dorsal raphe nucleus. Its combined screening, behavioral, neuroimaging, and mechanistic design links PDZ-domain target engagement to altered serotonergic feedback and improved stress-related behaviors in mice.
-
Sulfo-NHS-Biotin for Nanovial Cell Profiling
2026-09-08
Sulfo-NHS-Biotin is a water-soluble, amine-reactive protein labeling reagent for controlled cell-surface tagging, affinity capture, and interaction assays. This guide translates its chemistry into practical workflows for nanovial-based single-cell profiling while separating established biotinylation practice from emerging platform applications.
-
Digoxin: From Ion Transport to Translation
2026-09-08
Digoxin is more than a cardiac glycoside: it is a mechanistically defined perturbation tool for connecting Na+/K+ ATPase inhibition with cardiac phenotypes, cell-specific chikungunya responses, and exposure-aware translational design.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-09-07
α-Bungarotoxin is a high-affinity α7 nicotinic acetylcholine receptor antagonist used to test nicotinic receptor blockade. The B6950 material supports controlled neuroscience research, receptor pharmacology, and mechanistic cholinergic signaling studies, but it is not a diagnostic or therapeutic product.
-
Isochlorogenic acid A: Hydrogel Workflow
2026-09-07
Learn how Isochlorogenic acid A can be deployed in solvent-aware natural product assays and multifunctional wound-repair hydrogels. This practical workflow connects 3,5-Dicaffeoylquinic acid handling with antimicrobial, cell-migration, and inflammation-oriented readouts while separating literature findings from optimization recommendations.
-
One-step TUNEL Cy3 Apoptosis Detection Kit for GBM
2026-09-05
Connect mitochondrial stress to a measurable cell-death endpoint with spatial microscopy or flow cytometry. This workflow shows how the One-step TUNEL Cy3 Apoptosis Detection Kit supports apoptosis detection in tissue sections and cultured glioblastoma cells while avoiding overinterpretation of DNA-break signals.
-
4μ8C: Practical IRE1α Inhibition Workflows
2026-09-04
Use 4μ8C as a pathway-dissection tool for separating IRE1α RNase activity from broader ER-stress toxicity in hypoxia and cancer models. This guide combines solvent handling, treatment design, orthogonal readouts, and troubleshooting for more reproducible unfolded protein response experiments.
-
Chloroquine Mechanisms in Cancer Therapy
2026-09-04
This 2024 review organizes the anticancer pharmacology of Chloroquine across autophagy-dependent and autophagy-independent mechanisms, emphasizing lysosomal, mitochondrial, apoptotic, and signaling effects. Its practical contribution is a framework for interpreting combination-treatment evidence while keeping toxicity, mechanistic ambiguity, and clinical translation in view.
-
One-step TUNEL Cy3 Kit for CRC Apoptosis
2026-09-03
Discover how the One-step TUNEL Cy3 Apoptosis Detection Kit can clarify DNA fragmentation in colorectal cancer models. This guide connects AKT1-directed pharmacology, translational tissue analysis, and rigorous apoptosis assay design.